EMBR LABS SECURES $35 MILLION TO FUND MARKET EXPANSION
The Embr Wave® wristband, using Embr's patented technology, delivers precisely calibrated cooling or warming sensations at the touch of a button for instant, discrete control over hot flashes and related menopause symptoms. Clinical research has shown that using Embr Wave gives you immediate relief from hot flashes and improves sleep.
"Women today are seeking natural, non-hormonal alternatives to control their symptoms of menopause, and the Embr Wave is the solution they've been looking for," said Elizabeth Gazda, CEO of Embr Labs. "Through our partnership with Ghost Tree, Embr Labs is able to accelerate the fulfillment of our mission to provide this ground-breaking technology to women everywhere."
The influx of new capital will support Embr's rapid growth and continued expansion into new retail channels and markets. Embr Labs has secured partnerships with some of the most recognized distribution and retail organizations, with Embr Wave now available at most major retailers across the US and
"We recognized Embr's market leadership and the company's rapid growth potential," said David Byrne, Managing Director, Ghost Tree Partners. "We are pleased to support the company as the investment community has yet to recognize the massive unmet need the menopause segment presents. We're excited to provide the capital to support the company's retail growth and geographical expansion."
"Innovation drives growth, and intellectual property can be the valuable asset created from that innovation," said Lewis Lee, CEO, IP Solutions at Aon, a global professional services firm that facilitated the transaction through valuation and broking services. "We are excited to support innovative companies with intellectual property portfolios like Embr Labs to help them unlock the potential value of those IP assets and pursue growth independent of equity market volatility."
About Embr Labs, Inc.
Embr Labs is the leading healthtech company addressing the symptoms of menopause by pioneering the use of temperature as a new pathway to the brain. Embr Wave is now distributed through major US retailers, as well as Boots.com in the
About Ghost Tree Partners
Headquartered in
About Aon
Aon plc (NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Our colleagues provide our clients in over 120 countries and sovereignties with advice and solutions that give them the clarity and confidence to make better decisions to protect and grow their business.
Follow Aon on LinkedIn, Twitter, Facebook and Instagram. Stay up-to-date by visiting the Aon Newsroom and sign up for News Alerts here.
Information Concerning Forward-Looking Statements
This communication contains certain statements related to future results, or states Aon's intentions, beliefs and expectations or predictions for the future which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from either historical or anticipated results depending on a variety of factors. These forward-looking statements include information about possible or assumed future performance and results of Aon's operations. All statements other than statements of historical facts that address activities, events or developments that Aon expects or anticipates may occur in the future, including such things as its outlook, business strategies, competitive strengths, goals, the benefits of new initiatives, growth of its business and operations, plans, references to future successes, are forward-looking statements. Also, when Aon uses the words such as "anticipate", "believe", "estimate", "expect", "intend", "plan", "probably", "potential", "looking forward", or similar expressions, it is making forward-looking statements.
Any or all of Aon's forward-looking statements may turn out to be inaccurate, and there are no guarantees about Aon's performance. Aon and its subsidiaries operate in a dynamic business environment in which new risks may emerge frequently. Accordingly, you should not place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. In addition, results for prior periods are not necessarily indicative of results that may be expected for any future period. Further information concerning Aon and its businesses, including factors that potentially could materially affect Aon's financial results, is contained in Aon's filings with the Securities and Exchange Commission (the "SEC"). See Aon's Annual Report on Form 10-K for the year ended December 31, 2022, for a further discussion of these and other risks and uncertainties applicable to Aon and its businesses. These factors may be revised or supplemented in subsequent reports filed with the SEC. Aon is not under, and expressly disclaims, any obligation to update or alter any forward-looking statement that it may make from time to time, whether as a result of new information, future events or otherwise. Aon is not responsible for information contained in this communication relating to any borrower or potential borrower, including statements regarding a borrower's operations, products or services.
CONTACT: margaret@embrlabs.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/embr-labs-secures-35-million-to-fund-market-expansion-301814905.html
SOURCE Embr Labs
